[OpDis Editor Note: This was the plan all along right? Create a virus, release it, let it spread, create a vaccine, make money, create a drug for it, make more money. COVID will eventually be treated like the Flu.]
Source: Bangkok Post
PUBLISHED : 5 NOV 2021 AT 19:55
Pfizer says Covid pill 89% effective
CEO calls new medication a ‘game changer’, FDA approval to be sought
WASHINGTON: Pfizer said on Friday that a clinical trial of its pill to treat Covid-19 had shown it is highly effective.
The drug called Paxlovid is the second anti-Covid pill after that of Merck, which is actually an influenza medicine rebranded to fight the coronavirus. Pfizer said its medication had been created specifically to fight Covid.
The drug achieved an 89% reduction in risk of hospitalisation or death among adult patients with Covid who are at high risk of progressing to severe illness, the US company said.
The results from the middle- to late-stage clinical trial were so strong that Pfizer will stop recruiting new people for the trial, the company said.
It will submit the data to the Food and Drug Administration as soon as possible as part of its “rolling submission” for Emergency Use Authorisation.
“Today’s news is a real game-changer in the global efforts to halt the devastation of this pandemic,” said Pfizer CEO Albert Bourla.
“These data suggest that our oral antiviral candidate, if approved or authorised by regulatory authorities, has the potential to save patients’ lives, reduce the severity of Covid-19 infections, and eliminate up to nine out of 10 hospitalisations.”
The main analysis of the data looked at numbers from 1,219 adults in North and South America, Europe, Africa and Asia.
Several companies are working on oral antivirals, which would mimic what the drug Tamiflu does for influenza and prevent the disease from progressing to severe.
Pfizer started developing its drug in March 2020.
Britain on Thursday became the first country to approve an anti-Covid pill, as it okayed the use of Merck’s antiviral drug called molnupiravir to treat patients suffering from mild to moderate coronavirus.
Pfizer’s product is known as a “protease inhibitor” and has been shown in lab testing to jam up the virus’ replication machinery. If it works in real life, it will likely only be effective at the early stages of infection.
By the time Covid progresses to a severe disease, the virus has largely stopped replicating and patients suffer from an overactive immune response.
A simple pill to treat the coronavirus has been sought since the start of the pandemic.
Until now, Covid therapeutics such as monoclonal antibodies and remdesivir — a drug made by Gilead and authorised for use in the EU under the name Veklury — have been administered intravenously.
Molnupiravir was initially developed as an inhibitor of influenza and respiratory syncytial virus — two other important acute respiratory infections — by a team at Emory University in Atlanta, Georgia.
Britain, which has been one of the countries hardest hit by the pandemic, announced on Oct 20 that it had ordered 480,000 doses of molnupiravir.
If you wish to write and/or publish an article on Operation Disclosure all you need to do is send your entry to UniversalOm432Hz@gmail.com applying these following rules.
The subject of your email entry should be: “Entry Post | (Title of your post) | Operation Disclosure”
– Must be in text format
– Proper Grammar
– No foul language
– Your signature/name/username at the top
If you wish to receive the daily Operation Disclosure Newsletter, you can subscribe via the PayPal “Subscribe” button located on the site.
Our mission at Operation Disclosure is to bring you important news events and raw intel from various sources focused on exposing the Deep State/Cabal and their downfall. We are also focused on disclosing our lost ancient origins and extraterrestrial contact.
Disclaimer: All articles, videos, and images posted on Operation Disclosure were submitted by readers and/or handpicked by the site itself for informational and/or entertainment purposes. All statements, claims, views and opinions that appear on this site are always presented as unverified and should be discerned by the reader. We do not endorse any opinions expressed on this website and we do not support, represent or guarantee the completeness, truthfulness, accuracy, or reliability of any content posted on this website.
Copyright © 2022 Operation Disclosure